Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$1.04B |
| 2 |
Gaotu Techedu
GOTU
|
+$1.03B |
| 3 |
Visa
V
|
+$749M |
| 4 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$517M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$515M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$4.43B |
| 2 |
Invesco QQQ Trust
QQQ
|
+$2.58B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$759M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$643M |
| 5 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$595M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.23% |
| 2 | Consumer Discretionary | 8.46% |
| 3 | Healthcare | 7.67% |
| 4 | Financials | 7.46% |
| 5 | Communication Services | 6.12% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1826
Mohawk Industries
MHK
$8.97B
| $20.8M | 0.01% |
147,325
-315,847
| -68% | -$38.1M |
|
1827
iShares US Healthcare Providers ETF
IHF
$1.25B
| $20.7M | 0.01% |
441,290
-59,775
| -12% | -$2.65M |
|
1828
Leggett & Platt
LEG
$1.31B
| $20.7M | 0.01% |
466,965
-329,575
| -41% | -$14.1M |
|
1829
The Mosaic Company
MOS
$7.46B
| $20.7M | 0.01% |
898,574
-1,092,249
| -55% | -$22M |
|
1830
MACOM Technology Solutions
MTSI
$23B
| $20.6M | 0.01% |
374,841
-27,030
| -7% | -$1.15M |
|
|
X
1831
DELISTED
US Steel
X
| $20.6M | 0.01% |
1,229,895
-1,550,556
| -56% | -$19.3M |
|
1832
Levi Strauss
LEVI
$9.35B
| $20.6M | 0.01% |
1,026,875
+922,165
| +881% | +$16.5M |
|
|
OPLN
1833
Openlane
OPLN
$4.62B
| $20.6M | 0.01% |
1,106,191
-167,600
| -13% | -$2.89M |
|
1834
PUT
Clorox
CLX
$12.8B
| $20.5M | 0.01% |
101,600
-48,200
| -32% | -$9.97M |
|
|
CNST
1835
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
| $20.5M | 0.01% |
711,665
+341,483
| +92% | +$8.6M |
|
|
AXON
1836
Axon Enterprise
AXON
$42.1B
| $20.5M | 0.01% |
167,057
+76,536
| +85% | +$8.78M |
|
|
BHVN
1837
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $20.4M | 0.01% |
237,600
+199,600
| +525% | +$16.9M |
|
|
NUVA
1838
CALL
DELISTED
NuVasive, Inc.
NUVA
| $20.4M | 0.01% |
361,400
+400
| +0.1% | +$19.7K |
|
1839
Lamar Advertising Co
LAMR
$16.2B
| $20.3M | 0.01% |
244,475
-398,108
| -62% | -$29.8M |
|
1840
Nomura Holdings
NMR
$29B
| $20.3M | 0.01% |
3,801,862
+141,358
| +4% | +$699K |
|
1841
PUT
Rocket Companies
RKT
$37.4B
| $20.2M | 0.01% |
+1,000,200
| New | +$21.1M |
|
|
MNRL
1842
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
| $20.2M | 0.01% |
1,836,254
-79,138
| -4% | -$816K |
|
1843
iShares US Equity Factor ETF
LRGF
$3.68B
| $20.2M | 0.01% |
535,508
-58,492
| -10% | -$2.08M |
|
1844
CALL
SolarEdge
SEDG
$1.99B
| $20.2M | 0.01% |
63,200
-68,800
| -52% | -$19M |
|
1845
UDR
UDR
$12.3B
| $20.2M | 0.01% |
524,539
-293,953
| -36% | -$10.7M |
|
1846
Wheaton Precious Metals
WPM
$56.9B
| $20.1M | 0.01% |
482,533
-254,657
| -35% | -$11.4M |
|
1847
Bausch Health
BHC
$2.21B
| $20.1M | 0.01% |
967,812
+171,481
| +22% | +$3.2M |
|
1848
Revolution Medicines
RVMD
$42.1B
| $20.1M | 0.01% |
507,066
+453,272
| +843% | +$17.9M |
|
|
SWIR
1849
DELISTED
Sierra Wireless
SWIR
| $20M | 0.01% |
1,368,313
-12,622
| -0.9% | -$159K |
|
1850
Medpace
MEDP
$16.3B
| $19.9M | 0.01% |
143,192
+29,322
| +26% | +$3.7M |
|
Similar funds
Goldman Sachs's Q4 2020 Portfolio in Review
As of Q4 2020, Goldman Sachs held 5,916 positions worth $389B, up 10% from $352B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Goldman Sachs withdrew a net $17.4B in Q4 2020, closing 466 positions and reducing 2,520 holdings. Its most notable exit was Immunomedics Inc, an estimated $418M position sold in full.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Goldman Sachs opened a new position in Chindata Group Holdings Limited American Depositary Shares worth $290M.
- Goldman Sachs's largest Q4 2020 buy was Chindata Group Holdings Limited American Depositary Shares: 12,107,899 shares worth $290M.
- Goldman Sachs added most to iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2020, an estimated $1.04B increase.
- Goldman Sachs's biggest Q4 2020 reduction was Tesla, cutting an estimated $4.43B.
- Goldman Sachs fully exited Immunomedics Inc in Q4 2020, selling an estimated $418M.
- Goldman Sachs's ten largest holdings make up 20% of its $389B portfolio in Q4 2020.
- Goldman Sachs opened 643 new positions and closed 466 in Q4 2020.
- Goldman Sachs's portfolio value rose 10% quarter-over-quarter to $389B.
Based on Goldman Sachs's 13F filing for Q4 2020, filed 12 Feb 2021.